1. Home
  2. CVCO vs HAE Comparison

CVCO vs HAE Comparison

Compare CVCO & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVCO
  • HAE
  • Stock Information
  • Founded
  • CVCO 1965
  • HAE 1971
  • Country
  • CVCO United States
  • HAE United States
  • Employees
  • CVCO N/A
  • HAE N/A
  • Industry
  • CVCO Homebuilding
  • HAE Medical/Dental Instruments
  • Sector
  • CVCO Consumer Discretionary
  • HAE Health Care
  • Exchange
  • CVCO Nasdaq
  • HAE Nasdaq
  • Market Cap
  • CVCO 3.6B
  • HAE 3.3B
  • IPO Year
  • CVCO N/A
  • HAE 1991
  • Fundamental
  • Price
  • CVCO $544.99
  • HAE $52.21
  • Analyst Decision
  • CVCO Buy
  • HAE Buy
  • Analyst Count
  • CVCO 2
  • HAE 10
  • Target Price
  • CVCO $522.50
  • HAE $84.20
  • AVG Volume (30 Days)
  • CVCO 168.0K
  • HAE 945.0K
  • Earning Date
  • CVCO 10-30-2025
  • HAE 11-06-2025
  • Dividend Yield
  • CVCO N/A
  • HAE N/A
  • EPS Growth
  • CVCO 34.06
  • HAE 46.89
  • EPS
  • CVCO 23.02
  • HAE 3.28
  • Revenue
  • CVCO $2,094,716,000.00
  • HAE $1,346,046,000.00
  • Revenue This Year
  • CVCO $9.80
  • HAE N/A
  • Revenue Next Year
  • CVCO $6.01
  • HAE $6.50
  • P/E Ratio
  • CVCO $23.67
  • HAE $15.93
  • Revenue Growth
  • CVCO 16.60
  • HAE 0.91
  • 52 Week Low
  • CVCO $393.53
  • HAE $50.68
  • 52 Week High
  • CVCO $568.97
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • CVCO 66.80
  • HAE 30.00
  • Support Level
  • CVCO $533.30
  • HAE $53.10
  • Resistance Level
  • CVCO $555.70
  • HAE $54.52
  • Average True Range (ATR)
  • CVCO 14.85
  • HAE 1.22
  • MACD
  • CVCO -0.54
  • HAE 0.53
  • Stochastic Oscillator
  • CVCO 60.14
  • HAE 7.61

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: